Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax
August 13, 2018 11:59 ET
|
Emergent BioSolutions
Adds two revenue-generating FDA-licensed vaccines that protect against cholera and typhoid fever, both with dual-market potentialBroadens development pipeline with an adenovirus 4/7 vaccine funded by...
Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax
August 09, 2018 06:30 ET
|
Emergent BioSolutions
Adds two revenue-generating FDA-licensed vaccines that protect against cholera and typhoid fever, both with dual-market potentialBroadens development pipeline with an adenovirus 4/7 vaccine funded by...
Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic
July 31, 2018 16:30 ET
|
Emergent BioSolutions
ZIKV-IG granted Fast Track designation by the U.S. Food and Drug Administration GAITHERSBURG, Md., July 31, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the...
Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
June 08, 2018 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will present a corporate overview and...
Emergent BioSolutions Announces $50 Million Expansion of Baltimore Fill/Finish Facility
June 07, 2018 06:30 ET
|
Emergent BioSolutions
Multi-year investment will support growth of contract development and manufacturing capabilities GAITHERSBURG, Md., June 07, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today...
CEPI、ニパウィルスのワクチン開発に向けて、プロフェクタス･バイオサイエンスおよびエマージェント･バイオソリューションと、2,500万ドル (約27億円) の契約を締結
May 27, 2018 18:00 ET
|
Emergent Biosolutions, Inc.
日 オスロ (ノルウェー)、ボルティモアおよびメリーランド州ゲイサーズバーグ発, May 28, 2018 (GLOBE NEWSWIRE) -- CEPI (伝染病蔓延対策の革新のための連合、Coalition for Epidemic Preparedness Innovations) は本日、プロフェクタス･バイオサイエンス (Profectus BioSciences, Inc.)...
CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine
May 27, 2018 18:00 ET
|
Emergent BioSolutions
OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 27, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus...
CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine
May 24, 2018 06:11 ET
|
Emergent BioSolutions
OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus...
Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries
April 12, 2018 06:30 ET
|
Emergent Biosolutions, Inc.
GAITHERSBURG, Md., April 12, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market...
Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy
March 26, 2018 16:30 ET
|
Emergent Biosolutions, Inc.
GAITHERSBURG, Md., March 26, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced executive management changes that continue to align its organizational structure to its...